New Halogen-Containing Drugs Approved by FDA in 2021: An Overview on Their Syntheses and Pharmaceutical Use
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New Halogen-Containing Drugs Approved by FDA in 2021: An Overview on Their Syntheses and Pharmaceutical Use
Authors
Keywords
-
Journal
MOLECULES
Volume 27, Issue 5, Pages 1643
Publisher
MDPI AG
Online
2022-03-03
DOI
10.3390/molecules27051643
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
- (2022) Zhao Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective electrophilic di- and monofluorinations for the synthesis of 4-difluoromethyl and 4-fluoromethyl quinazolin(thi)ones by a Selectfluor-triggered multi-component reaction
- (2022) Ruiqin Zhang et al. Organic Chemistry Frontiers
- Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma
- (2021) Nathan H. Fowler et al. JOURNAL OF CLINICAL ONCOLOGY
- Melphalan Flufenamide (Melflufen): First Approval
- (2021) Sohita Dhillon DRUGS
- Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study
- (2021) Ludwig Kappos et al. JAMA Neurology
- Practical Synthesis and Application of Halogen-Doped Pyrrole Building Blocks
- (2021) Andrej Emanuel Cotman et al. ACS Omega
- The synthesis review of the approved tyrosine kinase inhibitors for anticancer therapy in 2015–2020
- (2021) Xiaoxia Liang et al. BIOORGANIC CHEMISTRY
- Infigratinib: First Approval
- (2021) Connie Kang DRUGS
- Piflufolastat F 18: Diagnostic First Approval
- (2021) Susan J. Keam Molecular Diagnosis & Therapy
- Fluorine-containing pharmaceuticals approved by the FDA in 2020: Synthesis and biological activity
- (2021) Yingjie Yu et al. CHINESE CHEMICAL LETTERS
- Manufacturing Process Development for Belzutifan, Part 5: A Streamlined Fluorination–Dynamic Kinetic Resolution Process
- (2021) Tao Wang et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Manufacturing Process Development for Belzutifan, Part 3: Completing a Streamlined Through-Process with a Safe and Scalable Oxidation
- (2021) Zhiwei Chen et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Manufacturing Process Development for Belzutifan, Part 4: Nitrogen Flow Criticality for Transfer Hydrogenation Control
- (2021) Nastaran Salehi Marzijarani et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Manufacturing Process Development for Belzutifan, Part 2: A Continuous Flow Visible-Light-Induced Benzylic Bromination
- (2021) Cecilia Bottecchia et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Manufacturing Process Development for Belzutifan, Part 1: A Concise Synthesis of the Indanone Starting Material
- (2021) Feng Peng et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Manufacturing Process Development for Belzutifan, Part 6: Ensuring Scalability for a Deoxyfluorination Reaction
- (2021) Michael Pirnot et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Recent Advances in the Application of Selectfluor as a “Fluorine‐free” Functional Reagent in Organic Synthesis
- (2020) Ke Yang et al. Chemistry-An Asian Journal
- Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success
- (2020) Gene M. Dubowchik et al. JOURNAL OF MEDICINAL CHEMISTRY
- Contribution of Organofluorine Compounds to Pharmaceuticals
- (2020) Munenori Inoue et al. ACS Omega
- Editorial Commentary: Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study
- (2020) Mary E. Westerman et al. Annals of Translational Medicine
- Tackling Antibiotic Resistance with Compounds of Natural Origin: A Comprehensive Review
- (2020) Francisco Javier Álvarez-Martínez et al. Biomedicines
- The prevalence and impact of migraine and severe headache in the United States: Updated age, sex, and socioeconomic‐specific estimates from government health surveys
- (2020) Rebecca Burch et al. HEADACHE
- Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives
- (2020) Wei Zheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Review of Synthetic Routes and Final Forms of Integrase Inhibitors Dolutegravir, Cabotegravir, and Bictegravir
- (2019) David L. Hughes ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Fluorine‐Containing Drugs Approved by the FDA in 2018
- (2019) Haibo Mei et al. CHEMISTRY-A EUROPEAN JOURNAL
- Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review
- (2019) Wan-Yin Fang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma
- (2019) Rui Xu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors
- (2019) Brian A. Lanman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study
- (2018) Howard A Burris et al. LANCET ONCOLOGY
- Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1
- (2018) Joseph Schoepfer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacokinetics and Pharmacodynamics of Cabotegravir, a Long-Acting HIV Integrase Strand Transfer Inhibitor
- (2018) Dario Cattaneo et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure
- (2017) Markus Follmann et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of the Irreversible Covalent FGFR Inhibitor 8-(3-(4-Acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (PRN1371) for the Treatment of Solid Tumors
- (2017) Ken A. Brameld et al. JOURNAL OF MEDICINAL CHEMISTRY
- The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1
- (2017) Andrew A. Wylie et al. NATURE
- Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
- (2015) Andrew F. Russo Annual Review of Pharmacology and Toxicology
- An intramolecular C–N cross-coupling of β-enaminones: a simple and efficient way to precursors of some alkaloids ofGalipea officinalis
- (2015) Hana Doušová et al. Beilstein Journal of Organic Chemistry
- Does Fluorine Participate in Halogen Bonding?
- (2015) Kiamars Eskandari et al. CHEMISTRY-A EUROPEAN JOURNAL
- An Efficient and Highly Diastereoselective Synthesis of GSK1265744, a Potent HIV Integrase Inhibitor
- (2015) Huan Wang et al. ORGANIC LETTERS
- Epidemiologie der Multiplen Sklerose in Deutschland
- (2014) G. Petersen et al. NERVENARZT
- Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase
- (2011) Vito Guagnano et al. JOURNAL OF MEDICINAL CHEMISTRY
- Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug Design
- (2010) Marcelo Hernandes et al. CURRENT DRUG TARGETS
- 2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1Receptor Agonists
- (2010) Martin H. Bolli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Halogenated Compounds from Marine Algae
- (2010) Maria Teresa Cabrita et al. Marine Drugs
- Halogenation Strategies In Natural Product Biosynthesis
- (2008) Christopher S. Neumann et al. CHEMISTRY & BIOLOGY
- Use of fluorinated functionality in enzyme inhibitor development: Mechanistic and analytical advantages
- (2008) David B. Berkowitz et al. JOURNAL OF FLUORINE CHEMISTRY
- Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA)
- (2008) Sangeeta R. Banerjee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fluorine in medicinal chemistry
- (2007) Sophie Purser et al. CHEMICAL SOCIETY REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now